Excluded from today's screen — already covered in the last 7 days.
| Company | Researched on |
|---|---|
| SEIBU HOLDINGS INC (9024) | 2026-05-30 |
| ZOZO INC (3092) | 2026-05-31 |
| SRE HLDGS CORP (2980) | 2026-06-01 |
| NTT INC (9432) | 2026-06-02 |
| ASAHI GROUP HLDGS (2502) | 2026-06-03 |
| CAPCOM CO LTD (9697) | 2026-06-04 |
| Company | Opportunity | Core moat damage | Rationale |
|---|---|---|---|
| ONCOTHERAPY SCIENCE INC (4564) | 1 | 9 | No proven moat, fourteen years of losses, tiny R&D sales, impairment, and patent-life decay point to structural value erosion; upside depends on low-visibility clinical or licensing events while dilution risk stays high. |
| SOLASIA PHARMA K K (4597) | 2 | 8 | Asset-specific exclusivity remains, but China pricing pressure, impairment, and repeated partner failures show weak economic capture; upside is still deal-dependent and likely diluted. |
| METAPLANET INC (3350) | 3 | 7 | The Japan Bitcoin-proxy angle has scarcity value, but serial issuance, warrant overhang, and funding reflexivity erode per-share exposure; BTC upside exists, yet much of it leaks to new capital providers. |
| DAIICHI SANKYO COMPANY LIMITED (4568) | 6 | 4 | This is one of the stronger real moats in the set: ADC platform, know-how, and partner reach remain valuable. But OS misses narrowed monetizable breadth, and the equity case is now heavily tied to one major readout. |
| BEAT HOLDINGS LTD (9399) | 1 | 10 | No durable moat is evident. Capital scarcity, expensive financing, and strategic drift entrench subscale economics, making downside reflexive and upside largely exogenous. |
| JFE HOLDINGS INC (5411) | 4 | 5 | Domestic scale and qualification advantages still exist, but Chinese oversupply and underutilization are pressuring the economic expression of those moats; recovery needs several external improvements at once. |
| WEST JAPAN RAILWAY CO (9021) | 6 | 2 | The core rail and station monopoly remains intact and essential. Current pressure is mainly cost inflation and monetization lag, but capex and non-rail expansion keep the near-term payoff only moderately attractive. |
| SKYLARK HOLDINGS CO LTD (3197) | 5 | 3 | Procurement scale, logistics, and footprint density remain intact, and may even strengthen relative to smaller peers. Still, value perception is being tested by repeated price hikes while labor, FX, and expansion leverage stack near-term risk. |
| TOKYO METRO CO LTD (9023) Selected | 8 | 1 | The Tokyo rail monopoly is intact, demand is utility-like, and the current earnings squeeze is mainly a timing gap between sticky costs and fare pass-through. Relative to the set, this is the cleanest intact-moat setup with bounded downside and a plausible earnings unlock. |
| MODALIS THERAPEUTICS CORP (4883) | 2 | 8 | The underlying IP may still be viable, but delay permanently burns patent life, weakens credibility, and pushes value realization further out. Adjustable financing makes common-equity outcomes highly path-dependent. |
| THE WHY HOW DO COMPANY INC (3823) Smart Money | 1 | 9 | The roll-up's only plausible moat, cheap capital plus integration skill, is directly damaged by reset warrants, going-concern risk, and weak control signals. Upside requires multiple structural repairs before shareholders benefit. |
| WIZE INC (3664) | 1 | 9 | Validator and treasury economics have little intrinsic moat, and floating-price financing plus going-concern risk directly undermine the only plausible asset, trust. Per-share upside remains fragile and commodity-linked. |
| GMO INTERNET INC (4784) | 5 | 4 | Core internet infrastructure remains a real moat with sticky workflows and brand trust, but advertising is structurally weaker and GPU cloud is capital-intensive with unproven defensibility. Interesting, but not clean enough to rank at the top. |
| CYBERSTEP HLDGS INC (3810) | 1 | 8 | Already-thin moats are eroding as utilization falls, competitors fragment demand, and liquidity limits UA and product investment. Any recovery is financing-dependent and likely diluted. |
| KEISEI ELECTRIC RAILWAY CO (9009) | 6 | 2 | Protected rail corridors and Narita access remain strong moats, but regulated pricing lag, higher rates, and heavy capex keep upside more conditional. The business is protected, though near-term asymmetry is not as favorable as the best rail name here. |
Why this company was selected: 9023 offers the best risk-adjusted asymmetry in this set: the core moat is essentially undamaged, demand is resilient, and the current earnings pressure looks more timing-based than structural. Unlike the biotech, crypto, and financing-dependent names, downside is bounded by a utility-like franchise, while even modest fare pass-through can have high flow-through to earnings. Relative to peers, it is the clearest case of temporary monetization pressure on top of an intact monopoly.
Tokyo Metro is the core subway operator in central Tokyo. It runs 9 lines, 180 stations, and about 195 kilometers of track, mostly inside the 23 wards. In FY2025 it carried an average of 6.84 million passengers a day. This is not a peripheral transport asset. It is one of the central pieces of Tokyo’s daily economic plumbing.
Data freshness matters here. The latest clean official annual base is FY2025. More recent data is FY2026 full-year results announced on April 28, 2026, which are official company figures but still unaudited pending the annual securities report. Current share price and market capitalization are market data observed on 2026-06-04. Tokyo Metro’s next official update is FY2027 Q1, scheduled for late July 2026.
At roughly ¥1,520 per share, the equity is worth about ¥885 billion. The stock is about 20% below its roughly ¥1,900 52-week high and only a little above its roughly ¥1,492 52-week low. The company listed only in October 2024, so a lot of what the market is doing now is still post-IPO price discovery rather than a mature long-term valuation.
Tokyo Metro makes most of its money from moving people through central Tokyo. The non-rail businesses matter, but they are still secondary. Real estate, station retail, advertising, and telecom-related leasing help, yet the economics are still driven primarily by passenger transport.
| Core economics | Value | Classification |
|---|---|---|
| Market cap | About ¥885 billion | Market data |
| Net cash / (net debt) | About (¥1,003 billion) including new-line construction loans; about (¥811 billion) excluding them | FY2026 full-year company results release, unaudited |
| Net income (TTM) | About ¥59.0 billion | FY2026 full-year company results release, unaudited |
| P/E | About 15.0x on FY2026 TTM; about 17.7x on FY2027 company guidance; roughly 15x to 16x normalized | Market data / company guidance / own estimate |
Growth. Over an audited 5-year view, this is basically a low-growth utility-like business interrupted by COVID rather than a secular grower. Revenue from FY2020 to FY2025 was roughly flat to slightly down on a CAGR basis, and net income over that span compounded only at low single digits. The stronger 3-year numbers are mostly recovery math from the post-pandemic trough: FY2022 revenue was ¥306.9 billion, rising to ¥407.8 billion by FY2025, and net income rose from ¥13.4 billion to ¥53.7 billion. That is real improvement, but it is not the same as discovering a new growth engine.
What is actually driving growth? Two things. First, passenger transport revenue has recovered as central Tokyo office activity, leisure traffic, and inbound tourism improved. In FY2025, non-commuter transport revenue was ¥209.4 billion, above the FY2020 pre-COVID level of ¥191.4 billion, although commuter revenue at ¥130.0 billion was still below the FY2020 level of ¥155.2 billion. Second, smaller gains came from station retail, advertising media, and selective property acquisitions and openings.
Owner earnings sanity check. For cleanliness, this uses FY2025 audited numbers, not the still-unaudited FY2026 release.
| Owner earnings bridge | Amount | Classification |
|---|---|---|
| Net income | ¥53.7 billion | FY2025 audited annual data |
| Plus depreciation and amortization | ¥72.1 billion | FY2025 audited annual data |
| Less sustaining capex | About ¥72 billion to ¥75 billion | Own estimate, based on management’s statement that basic investments are funded broadly within depreciation |
| Plus / minus working capital | Not material for the rough estimate | Judgment |
| Rough owner earnings | About ¥51 billion to ¥54 billion | Own estimate |
That implies an owner earnings yield of about 5.8% to 6.1% on today’s market cap. It is not meaningfully different from the P/E view, because this is a mature rail asset where maintenance capex and depreciation are fairly close over time. The big cash drain is not hidden maintenance. It is growth capex: new lines, property development, and other strategic projects.
Capital efficiency. ROE improved from about 7.1% in FY2024 to 7.8% in FY2025 and is roughly 8% on the FY2026 full-year results release. ROIC is lower, roughly 3.5% to 4.5% depending on whether one includes the policy-backed new-line construction loans in invested capital. That is the key distinction. Tokyo Metro is a durable franchise, but not a high-return compounder. Incremental capital is mostly moat-protecting and socially necessary, not exceptionally profitable.
Business quality. Where do profits actually come from? Mostly transport. In FY2025, transportation generated ¥74.2 billion of the group’s ¥86.9 billion operating income. Real estate contributed ¥4.2 billion, and retail/advertising contributed ¥8.4 billion. This has been a good business because the network is nearly impossible to replicate: scarce right-of-way, dense coverage of central Tokyo, integration with the wider metro rail network, daily habitual demand, and public trust built over decades. The limitation is equally clear: fares are regulated, capital intensity is heavy, and the moat protects stability more than extraordinary reinvestment returns.
This is not a case where the business collapsed and the stock followed. It is a case where the market moved from IPO enthusiasm to a more sober view of Tokyo Metro as a regulated, capital-intensive, leveraged urban rail operator.
After the October 2024 listing, the stock traded up toward ¥1,900. It has since drifted down to the low ¥1,500s. The main reasons appear to be straightforward:
(a) One-time, cyclical, or sentiment-driven factors
(b) Medium-term business headwinds
(c) Potential long-term structural threats
Reality check versus the market narrative. The market has some things right and some things wrong.
| Concern | 2+ year quantitative reality check | Read-through |
|---|---|---|
| Demand is stalling | Passenger transport revenue rose from ¥281.4 billion in FY2023 to ¥324.0 billion in FY2024 to ¥339.4 billion in FY2025. Total passengers rose from 2.172 billion to 2.385 billion to 2.496 billion. | The network is still recovering. Total demand is improving. What is structurally weaker is commuter mix, not the whole franchise. |
| Hybrid work broke the economics | FY2025 commuter revenue was ¥130.0 billion versus ¥155.2 billion in FY2020, but non-commuter revenue was ¥209.4 billion versus ¥191.4 billion in FY2020. | This is a real mix shift, not a collapse in demand. Peak-hour commuter monetization is weaker, but leisure and non-commuter demand offset a lot of it. |
| Inflation is wrecking margins | Operating margin moved from 8.0% in FY2023 to 19.6% in FY2024 to 21.3% in FY2025. FY2026 was still about 21.2%. FY2027 guidance implies about 18.6%. | Margins are guided down, but from a strong level. This is a profit dip, not evidence of a broken cost structure. |
| Leverage is worsening | Net debt/EBITDA fell from 10.7x in FY2023 to 6.9x in FY2024 to 6.4x in FY2025 and 6.1x in FY2026. Excluding new-line construction loans, the ratio improved from 8.8x to 5.6x to 5.2x to 5.0x. | The balance sheet is still heavy, but directionally it is improving, not deteriorating. |
| Non-rail is becoming a major second engine | Non-rail operating income was roughly ¥13.0 billion in FY2023, ¥12.5 billion in FY2024, and ¥12.6 billion in FY2025. | The market should not pay a growth-platform multiple yet. This is still a rail-led earnings model. |
| FY2026 TTM fully represents earning power | Net income rose from ¥53.7 billion in FY2025 to ¥59.0 billion in FY2026, but FY2026 included roughly ¥6.4 billion of pension-plan revision gain. | The market is right to haircut the FY2026 headline P/E. |
Diagnosis: the current earnings problem is mostly time, not essence. The franchise is intact. The structural issues are more about ceiling on returns than about deterioration of the moat.
| Structural concern | Damaged mechanism | Does it damage core value creation? | Reversible within 3 years? | Classification |
|---|---|---|---|---|
| Hybrid work reduces commuter-pass demand | Peak-hour commuter monetization | Partly. It weakens one revenue stream, but not the utility of the network. | No, not fully. | (b) Real structural but survivable |
| Fare regulation caps pricing power | Price-led margin expansion | Yes, in the sense that it limits upside. No, in the sense that it does not undermine demand or the moat. | No. It is inherent to the business model. | (b) Real structural but survivable |
| Heavy capital intensity and modest incremental ROIC | Reinvestment engine | Yes. This is the main reason Tokyo Metro is a stable compounder of value, not a high-rate compounder. | Not really. It is built into subway economics. | (b) Real structural but survivable |
| Government sell-down overhang and the 2025 governance incident | Share price technicals and trust perception | No. These do not impair the tracks, stations, or passenger franchise. | Yes. | (c) Not truly structural |
There is no clear evidence of real structural damage to the moat itself. The rails are still where they were. The stations are still where they were. The passenger volumes are still rising. What is structurally constrained is pricing freedom and reinvestment return, not franchise durability.
Time-as-a-moat test.
The blockers are not just money. They are regulation, land and tunneling rights, network integration with other operators, public trust, safety culture, and decades of operational data. This is a genuine moat. The key nuance is that it is a regulated infrastructure moat, not a software moat. It protects continuity and relevance more than supernormal incremental returns.
Moat & Mispricing Score: 6/10. The market is too negative on the nature of the problem but only mildly negative on the price. Tokyo Metro’s moat is very strong and the current pressure is mostly a one-year earnings issue plus a technical overhang, not economic decay. But the market is also right that this is not a high-return compounder: leverage is high, pricing power is regulated, and incremental capital returns are only fair. So the stock looks fair to modestly cheap, not deeply mispriced.
At today’s market cap, the stock implies a normalized owner earnings yield of about 6.2% if one assumes owner earnings in the mid-¥50 billions. For a monopoly-like but leveraged, regulated rail asset, that is not obviously wrong. My own required equity yield is roughly 6.0% to 6.5% depending on how much credit one gives the moat versus the leverage and capital intensity.
| Case | Normalized owner earnings base | Required equity yield | Net cash / net debt adjustment | Implied equity value | Implied value per share | Vs. current price |
|---|---|---|---|---|---|---|
| Bear | ¥50 billion | 7.0% | None in the bridge; owner earnings are post-interest equity cash flow | ¥714 billion | About ¥1,229 | About -19% |
| Base | ¥56 billion | 6.0% | None in the bridge; owner earnings are post-interest equity cash flow | ¥933 billion | About ¥1,606 | About +5% |
| Bull | ¥60 billion | 5.5% | None in the bridge; owner earnings are post-interest equity cash flow | ¥1,091 billion | About ¥1,878 | About +23% |
Valuation basis. The bear case assumes the FY2027 earnings dip persists and normalized owner earnings settle around ¥50 billion. The base case assumes the current cost spike is temporary and owner earnings normalize in the mid-¥50 billions. The bull case assumes FY2026-like earning power can be sustained without moat damage. This is an intrinsic value estimate, not a price target.
So is the market wrong, and by how much? Probably not by much. My base-case equity value is around ¥930 billion versus the current market cap of about ¥885 billion, a gap of only roughly ¥50 billion, or about ¥80 per share. The more important market error is diagnostic: the market is treating a time problem in reported earnings as if it says something deeper about the franchise. The franchise is fine. The stock, however, is only mildly attractive because that franchise does not reinvest at high rates.
| Item | Value | Classification | Comment |
|---|---|---|---|
| Latest clean annual base | FY2025 | Audited annual data | Best clean base for owner-earnings work |
| FY2026 revenue / operating income / net income | ¥422.4bn / ¥89.6bn / ¥59.0bn | Official company full-year results release, unaudited | More current than FY2025, but not yet audited |
| FY2026 net income quality | Includes about ¥6.4bn pension-plan revision gain | Official company disclosure, unaudited | Headline TTM overstates normalized earning power |
| FY2027 guidance | Revenue ¥437.2bn, operating income ¥81.4bn, net income ¥50.0bn | Company guidance | Guides to higher sales but lower profits |
| Current share price / market cap | About ¥1,520 / ¥885bn | Market data | Observed 2026-06-04 |
| Net debt | About ¥1,003bn including new-line loans; about ¥811bn excluding them | FY2026 full-year results release, unaudited | Company itself tracks both figures |
| Sustaining capex | About ¥72bn to ¥75bn | Own estimate | Based on depreciation and management’s capital-allocation policy |
| Normalized owner earnings | About ¥50bn to ¥60bn | Own estimate | Centered on audited FY2025 base and adjusted for temporary FY2026/FY2027 effects |
| Intrinsic value range | ¥714bn to ¥1,091bn; about ¥1,229 to ¥1,878 per share | Own estimate | Equity yield framework, not a price target |
CoffeeAnd — 52-week low lens